The current prices are delayed, login to your account for live prices
Login
Venmax Drugs And Pharmaceuticals Shareholding Pattern
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
Total Promoters
Segment
Percent
Total Promoters
23.13%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0.15%
Retail
76.72%
Others
0%
Total Promoters
MAR '24
23.13%
JUN '24
23.13%
SEP '24
23.13%
DEC '24
23.13%
Venmax Drugs And Pharmaceuticals FAQs
As of 08-2025, the promoter shareholding in Venmax Drugs And Pharmaceuticals stands at 23.13% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Venmax Drugs And Pharmaceuticals is 0% and 0% respectively.
The retail shareholding of the Venmax Drugs And Pharmaceuticals is 76.87%.
Changes in shareholding patterns of Venmax Drugs And Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Venmax Drugs And Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.